LADAWNA ROYER: Open Payments
NPI 1215408968 · MACOMB, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$325 in 16 payments from 9 companies in 2025. Trend: 2023 $603 · 2024 $447 · 2025 $325
Food & beverage: $325
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $57 |
| Collegium Pharmaceutical, Inc. | 2 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
| ABBVIE INC. | 3 | $42 |
| Novo Nordisk Inc | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: FANAPT, Jornay PM, VRAYLAR, TRINTELLIX, INGREZZA, UZEDY, Wegovy, AUSTEDO XR.
Industry payments across IL — which companies pay providers there.
